en · de · es · fr · pt
sr9009-notes.peptides4088.com › Blog › Background And Receptor Pharmacology — Common Mistakes

Background And Receptor Pharmacology — Common Mistakes

By Editorial Desk · published 2025-11-29 · last reviewed 2025-12-20 · Blog

research chemical is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Last reviewed on 2025-12-20. Where a claim depends on a specific study, the study is described rather than over-claimed.

Background and Receptor Pharmacology

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.

Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.

Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.

Mechanism and Preclinical Findings

Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.

The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.

SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.

Sr9009 at a glance

PropertyValueNotes
Chemical classSynthetic REV-ERB agonistBinds REV-ERBα and REV-ERBβ in preclinical models
Molecular formulaC20H24ClN3O4SReported for the parent compound
CAS Registry Number1379686-30-2Common identifier in chemical databases
AppearanceOff-white to pale yellow solidTypical research chemical solid
SolubilitySoluble in DMSO and ethanol; low in waterClass: small organic molecule

Analytical Detection and Storage

Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.

Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.

Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.

Related pages on this site

Identity, Handling, and Regulation

In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.

Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.

Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.

Notes from published material

=== Characters === Nathan Byrn: The 17-year-old protagonist. He has straight black hair, olive skin and black eyes. He looks like his father. Raised in a family of White witches, but with a Black witch father, he is a Half Code. He can self-heal extraordinarily fast. Jessica Byrn: Nathan's oldest half-sister who hates him. She later becomes a Hunter. Arran Byrn: Nathan's half-brother, with whom Nathan has a loving relationship. Deborah Byrn: Nathan's half-sister. She (like Arran) loves Nathan. Marcus Edge: Nathan's father, the most feared Black witch of all time. He killed Nathan's siblings' father, among numerous others. His Gift is transforming into animals but he has also stolen Gifts from many other witches by killing them and eating their hearts. Cora Byrn: Nathan's mother, a White witch who died by suicide. Her gift was healing. Gabriel Boutin: A Black witch stuck in the body of a Fain. He helps Mercury to get Nathan to her in order to get his witch body back and later falls in love with Nathan. Annalise O'Brien: A White witch, some months older than Nathan. She runs away from her cruel family. She and Nathan were in love as young teens. Soul O'Brien: The uncle of Annalise and a White witch. Mercury: A powerful Black witch who has stolen the blood of every witch family. Rose: A White witch and Mercury's assistant, who always blushes and giggles. Celia: A White witch, Nathan's mentor with whom he was sent to live. She appears to treat Nathan cruelly and even would lock him in a cage.

==== Pharmaceutical copies ==== The pharmaceutical industry has revenues of hundreds of billions of dollars a year globally. With such a large industry counterfeiting and copyright infringement are serious issues, and hydrogen isotope fingerprinting has become a useful tool in verifying the authenticity of various drugs. As described in the preceding sections, the utility of DHRs is highest when combined with measurements of other isotope ratios. In an early study on the stable isotope compositions of tropicamide, hydrocortisone, quinine and tryptophan; carbon, nitrogen, oxygen and hydrogen stable isotopes were analyzed by EA-IRMS; clear distinctions were able to be made between manufacturers and even batches of the drugs based on their isotope signatures. In this study it was determined that the hydrogen and oxygen isotope ratios were the two best fingerprints for distinguishing between different drug sources. A follow-up study analyzing naproxen from various lots and manufacturers also showed similar ability to distinguish between sources of the drugs. The use of these isotope signatures could not only be used to distinguish between different manufacturers, but also between different synthetic pathways for the same compound. These studies relied on the natural variations that occurred in the synthesis of these drugs, but other studies have used starting ingredients that are intentionally labeled D and 13C, and showed that these labels could be traced into the final pharmaceutical product.

The FDA responded to the report by stating: Aspartame being labeled by IARC as "possibly carcinogenic to humans" does not mean that aspartame is actually linked to cancer. The FDA disagrees with IARC's conclusion that these studies support classifying aspartame as a possible carcinogen to humans. FDA scientists reviewed the scientific information included in IARC's review in 2021 when it was first made available and identified significant shortcomings in the studies on which IARC relied.

The number of horses killed was unprecedented in modern warfare. The wastage was particularly heavy among British forces for several reasons: overloading of horses with unnecessary equipment and saddlery, failure to rest and acclimatise horses after long sea voyages and, poor management by inexperienced mounted troops and distant control by unsympathetic staffs. The average life expectancy of a British horse, from the time of its arrival in Port Elizabeth, was around six weeks. Most horses and mules brought to South Africa came from the US. In total, 109,878 horses and 81,524 mules were shipped from New Orleans to South Africa in 166 voyages from October 1899 to June 1902. The cost of these animals and their transport was an average of US$597,978 per month. A significant number of horses and mules died during the transit; for example, during the SS Manchester City's 36-day passage, 187 of her 2,090 mules died. Horses were slaughtered for their meat when needed. During the sieges of Kimberley and Ladysmith, horses were consumed as food once regular sources were depleted. The besieged British forces in Ladysmith also produced chevril, a Bovril-like paste, by boiling down the horse meat to a jelly paste and serving it like beef tea. The Horse Memorial in Port Elizabeth is a tribute to the 300,000 horses that died during the conflict.

Sources: en.wikipedia.org

Background from the literature

The crab is defined as the intensity of X-rays emitted from the Crab Nebula at a given photon energy up to 30 kiloelectronvolts. The Crab Nebula is often used for calibration of X-ray telescopes. For measuring the X-ray intensity of a less energetic source, the milliCrab (mCrab) may be used. One crab is approximately 24 pW/m2.

== Notable incidents == In July 2009, Richard Torres, a correction officer at FMC Rochester, was indicted for smuggling contraband into the facility for an inmate in exchange for thousands of dollars in bribes. The contraband included cellular telephones, tobacco and creatine powder. Torres was terminated. Two months later, he pleaded guilty to soliciting a bribe and he was sentenced to one year in federal prison.

Boletus edulis, as the species epithet edulis (Latin: edible) indicates, is an edible mushroom. Italian chef and restaurateur Antonio Carluccio described it as representing "the wild mushroom par excellence", and hailed it as the most rewarding of all fungi in the kitchen for its taste and versatility. Considered a choice edible, particularly in France, Germany, Poland and Italy, it was widely written about by the Roman writers Pliny the Elder and Martial, although ranked below the esteemed Amanita caesarea. When he was served suilli instead of boleti, the disgruntled Martial wrote: sunt tibi boleti; fungos ego sumo suillos (Ep. iii. 60)("You eat the choice boletus, I have mushrooms that swine grub up.") The flavour of porcini has been described as nutty and slightly meaty, with a smooth, creamy texture, and a distinctive aroma reminiscent of sourdough. Young, small porcini are most appreciated, as the large ones often harbour maggots (insect larvae), and become slimy, soft and less tasty with age. The fruit bodies are collected by holding the stipe near the base and twisting gently. Cutting the stipe with a knife may risk the part left behind rotting and the mycelium being destroyed. Peeling and washing are not recommended. The fruit bodies are highly perishable, due largely to the high water content (around 90%), the high level of enzyme activity, and the presence of a flora of microorganisms.

Sources: en.wikipedia.org

Reference notes

=== Disease mechanism === Exactly how disturbances of production and aggregation of the Aβ peptide give rise to the pathology of Alzheimer's disease is not known. The amyloid hypothesis (also known as the 'amyloid cascade hypothesis') posits that the accumulation of abnormally shaped Aβ peptides is the central event triggering the sequence of changes that eventually lead to neurodegeneration and dementia. Misfolded Aβ accumulates in the brain because it causes normal Aβ molecules to similarly misfold by a prion-like 'seeding' mechanism. The aggregated Aβ takes the form of small oligomers (which are particularly toxic to neurons) and amyloid fibrils, the long polymers that are the main components of Aβ plaques. Some researchers have argued that the amyloid fibrils bind up smaller oligomers and thus protect brain cells from the injurious effects of the oligomers. However, the plaques are not benign inasmuch as they are associated with abnormal neuronal processes and local inflammation. Whatever the relative influence of Aβ oligomers and fibrils, the presence of aggregated Aβ is associated with the disruption of neuronal metabolism and various other changes such as inflammation. Aβ also selectively builds up in mitochondria in the cells of Alzheimer's-affected brains, and it inhibits certain enzyme functions and the utilisation of glucose by neurons. Evidence supports Aβ as playing a central role in the pathogenesis of Alzheimer's disease.

== Plot == Jesse (Danny McBride), Judy (Edi Patterson) and Kelvin (Adam DeVine) participate in a rehearsal for the "Aimee-Leigh Birthday Celebration Give-A-Thon", hosted by Baby Billy (Walton Goggins). However, during their attempt to lift up, the Gemstones' jet packs malfunction and ruin part of the set. Billy scolds them and demands that they find Eli, who has gone missing for the past few days, as he is vital to the Give-A-Thon's success. Eli (John Goodman) has moved to Florida, living in a yacht where he drinks alcohol and has sex with strangers. Jesse, Judy and Kelvin arrive to get him to take part in the telethon, but Eli refuses, feeling he needs time to consider what he truly wants in life. Nevertheless, they force him to change his mind after repeating the word "pussy" to annoy him. BJ (Tim Baltz) now attends pole dancing classes, although Judy feels jealous of his female colleagues. Kelvin and Keefe (Tony Cavalero) have embraced their relationship and formed a new church program named "Prism", although Keefe wishes they would finally marry or kiss in public. The Gemstones have also launched "Prayer Pods" to the market, but sales are incredibly low. Billy surprises the family by bringing Lori Milsap (Megan Mullally), Aimee-Leigh's long-time musical partner. She and Eli bond, reminiscing over their experiences with Aimee-Leigh. During the telethon, Eli is amazed upon seeing Lori singing, and has a flirtatious encounter with her backstage.

the presence of cytopenia at the time of diagnosis. the degree of modification of the capillaroscopy test (skin blood vessel study technique) of nail fold during follow-up. the presence of antinuclear antibodies. young age. severe vitamin D deficiency. the presence of anti-dsDNA, anti-Sm, and anti-cardiolipin autoantibodies correlates with the development of systemic lupus erythematosus in particular. The rate of progression is higher in the first five years following the onset of the disease and tends to decrease over time. Patients progressing to a defined disease seem to see a slight progression of the disease with a mitigated risk of developing complications.

Sources: en.wikipedia.org

Frequently asked questions

What is SR9009?

SR9009 is a synthetic small molecule studied as an agonist of the REV-ERB nuclear receptors. It is not an approved medicine, and its effects in humans are not well characterized.

Is SR9009 a hormone?

No. It is a synthetic ligand that binds nuclear receptors, not a steroid or peptide hormone. Its activity depends on receptor binding rather than endocrine secretion.

What is known about human use?

Clinical evidence is limited. Most published data come from cell and animal experiments. Human safety and efficacy remain uncertain.

What is SR9009?

It is a synthetic compound that acts as an agonist at REV-ERBα and REV-ERBβ. It is used mainly as a research chemical to study circadian and metabolic pathways. It is not approved for human therapeutic use.

Network